Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 462

1.

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.

Bernard CC, Johns TG, Slavin A, Ichikawa M, Ewing C, Liu J, Bettadapura J.

J Mol Med (Berl). 1997 Feb;75(2):77-88. Review.

PMID:
9083925
3.

Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein.

Slavin A, Ewing C, Liu J, Ichikawa M, Slavin J, Bernard CC.

Autoimmunity. 1998;28(2):109-20.

PMID:
9771980
5.

Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.

Ichikawa M, Johns TG, Adelmann M, Bernard CC.

Int Immunol. 1996 Nov;8(11):1667-74.

PMID:
8943561
7.

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.

Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C.

Glia. 2001 Nov;36(2):220-34. Review.

PMID:
11596130
9.

Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice.

Ben-Nun A, Kerlero de Rosbo N, Kaushansky N, Eisenstein M, Cohen L, Kaye JF, Mendel I.

Eur J Immunol. 2006 Feb;36(2):478-93.

10.

IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice.

Ichikawa M, Koh CS, Inaba Y, Seki C, Inoue A, Itoh M, Ishihara Y, Bernard CC, Komiyama A.

Cell Immunol. 1999 Feb 1;191(2):97-104.

PMID:
9973531
11.

Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.

Pöllinger B, Krishnamoorthy G, Berer K, Lassmann H, Bösl MR, Dunn R, Domingues HS, Holz A, Kurschus FC, Wekerle H.

J Exp Med. 2009 Jun 8;206(6):1303-16. doi: 10.1084/jem.20090299. Epub 2009 Jun 1.

13.

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.

Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu HC, Lassmann H, Wekerle H.

Eur J Immunol. 1993 Jun;23(6):1364-72.

PMID:
7684687
14.

The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.

Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu JM, Gardinier MV, Dornmair K, Linington C.

J Neuroimmunol. 1995 Dec;63(1):17-27.

PMID:
8557821
15.

Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.

Delarasse C, Daubas P, Mars LT, Vizler C, Litzenburger T, Iglesias A, Bauer J, Della Gaspera B, Schubart A, Decker L, Dimitri D, Roussel G, Dierich A, Amor S, Dautigny A, Liblau R, Pham-Dinh D.

J Clin Invest. 2003 Aug;112(4):544-53.

16.

T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.

Forsthuber TG, Shive CL, Wienhold W, de Graaf K, Spack EG, Sublett R, Melms A, Kort J, Racke MK, Weissert R.

J Immunol. 2001 Dec 15;167(12):7119-25.

17.

Characterization of the encephalitogenic immune response in a model of multiple sclerosis.

de Graaf KL, Barth S, Herrmann MM, Storch MK, Wiesmüller KH, Weissert R.

Eur J Immunol. 2008 Jan;38(1):299-308.

18.
19.

Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies.

Abo S, Bernard CC, Webb M, Johns TG, Alafaci A, Ward LD, Simpson RJ, Kerlero de Rosbo N.

Biochem Mol Biol Int. 1993 Aug;30(5):945-58.

PMID:
8220243
20.

Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.

Matsumoto Y, Park IK, Hiraki K, Ohtani S, Kohyama K.

Immunology. 2009 Sep;128(1 Suppl):e250-61. doi: 10.1111/j.1365-2567.2008.02955.x. Epub 2008 Oct 29.

Supplemental Content

Support Center